Percutaneous Nephrolithotomy Without a Ureteral Catheter
A Comparative Study of Retrograde Ureteral Catheter Insertion or Not in Percutaneous Nephrolithotomy
1 other identifier
interventional
200
1 country
1
Brief Summary
Conventional Percutaneous nephrolithotomy (PCNL) surgery requires the patient to first undergo retrograde transurethral ureteroscopic insertion of the ureteral catheter in the lithotomy position, and then change the patient to the prone position. However, repeated operation on the ureter can bring about immediate and long-term negative effects, such as ureteral false way formation, ureteral damage, perforation, avulsion, catheter insertion into the vena cava, pricking the kidney, increased postoperative pain, urinary extravasation, scar formation, and ureteral narrowing. The study planned to perform the operation in the prone position without reverse insertion of a ureteral catheter in the PCNL surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2022
CompletedFirst Posted
Study publicly available on registry
October 28, 2022
CompletedStudy Start
First participant enrolled
November 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFebruary 28, 2024
February 1, 2024
2 years
October 25, 2022
February 24, 2024
Conditions
Outcome Measures
Primary Outcomes (9)
Rate of fever
Fever was defined as axillary temperature greater than 38.5 ° C.
From the day of surgery to the day of discharge, up to 2 weeks.
White blood cell count change value
The change value of White blood cell count between preoperative and postoperative
Day 2 before surgery、hour 3 after the surgery
Neutrophils granulocyte change value
The change value of Neutrophils granulocyte between preoperative and postoperative
Day 2 before surgery、hour 3 after the surgery
Hemoglobin change value
The change value of Hemoglobin between preoperative and postoperative
Day 2 before surgery、hour 3 after the surgery
Hematocrit change value
The change value of Hematocrit between preoperative and postoperative
Day 2 before surgery、hour 3 after the surgery
Rate of renal subcapsular hematoma
The proportion of postoperative renal subcapsular hematoma in all patients
Day 2 after the surgery
Serum creatinine change value
The change value of Serum creatinine between preoperative and postoperative
Day 2 before surgery、Hour 3 after the surgery
visual analog scale (VAS)pain score
0: no pain; Less than 3 points: mild pain, tolerable; 4 points to 6 points: the patient's pain and affect sleep, still tolerable; 7-10: Patients have increasing pain, pain is unbearable, affect appetite, affect sleep.
Hour 2 after the surgery
Rate of hydrothorax
Hydrothorax appeared on the surgical side.
Day 2 after the surgery
Secondary Outcomes (4)
Stone free rate
Day 2 after the surgery
Operation time
During the procedure
length of hospital stay
2 weeks after surgery
Medical costs
2 weeks after surgery
Study Arms (2)
without reverse insertion of a ureteral catheter
EXPERIMENTALPercutaneous nephrolithotomy without reverse insertion of a ureteral catheter
Conventional
NO INTERVENTIONPercutaneous nephrolithotomy with reverse insertion of a ureteral catheter
Interventions
The ureteral catheter was not retrograde inserted during PCNL
Eligibility Criteria
You may qualify if:
- · Patients with upper urinary tract stones who were 18 years of age or older and eligible for PCNL surgery.
You may not qualify if:
- patients with infectious calculi confirmed by preoperative CT examination and blood biochemical indexes.
- Patients with severe cardiac and pulmonary insufficiency, coagulation dysfunction and other obvious surgical contraindications.
- Patients with previous history of PCNL surgery on the affected side or nephrotomy.
- Patients with indwelling double J tube or nephrostomy tube before operation.
- Patients with renal trauma or congenital anomalies of urinary system.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of University of South China
Hengyang, Hunan, 421001, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mingyong Li, MD.
the First Affiliated Hospital of the University of South China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 25, 2022
First Posted
October 28, 2022
Study Start
November 3, 2022
Primary Completion
November 1, 2024
Study Completion
February 1, 2025
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- One year after the study report was published,but the duration is uncertain.
- Access Criteria
- When proper editing or review requirements are met, the study data will be available from the study manager after the study is completed.
Individual participant data will be made available to other researchers after the study Report are published.